DFTX · Company research
Definium Therapeutics, Inc. Common Shares (DFTX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableBasic Materials
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 35.09 | $4,065,449,765.6 | 3410182765.60 | — | — | — | — | 4.4253213207224722 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.